JP2008525359A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008525359A5 JP2008525359A5 JP2007547368A JP2007547368A JP2008525359A5 JP 2008525359 A5 JP2008525359 A5 JP 2008525359A5 JP 2007547368 A JP2007547368 A JP 2007547368A JP 2007547368 A JP2007547368 A JP 2007547368A JP 2008525359 A5 JP2008525359 A5 JP 2008525359A5
- Authority
- JP
- Japan
- Prior art keywords
- mmol
- solution
- reaction mixture
- cooled
- stirred
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0428418.8A GB0428418D0 (en) | 2004-12-24 | 2004-12-24 | Organic compounds |
| PCT/EP2005/013897 WO2006066929A1 (en) | 2004-12-24 | 2005-12-22 | Quaternary ammonium salts as m3 antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008525359A JP2008525359A (ja) | 2008-07-17 |
| JP2008525359A5 true JP2008525359A5 (cg-RX-API-DMAC7.html) | 2009-02-26 |
Family
ID=34130968
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007547368A Pending JP2008525359A (ja) | 2004-12-24 | 2005-12-22 | M3アンタゴニストとしての第4級アンモニウム塩類 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8153669B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1831208B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2008525359A (cg-RX-API-DMAC7.html) |
| KR (1) | KR101259654B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN101080405B (cg-RX-API-DMAC7.html) |
| AT (1) | ATE521606T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2005318424B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0519292A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2589133A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2370832T3 (cg-RX-API-DMAC7.html) |
| GB (1) | GB0428418D0 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2007007722A (cg-RX-API-DMAC7.html) |
| PL (1) | PL1831208T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT1831208E (cg-RX-API-DMAC7.html) |
| RU (1) | RU2394031C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006066929A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0428416D0 (en) | 2004-12-24 | 2005-02-02 | Novartis Ag | Organic compounds |
| KR101495708B1 (ko) | 2007-02-23 | 2015-02-25 | 세라밴스 바이오파마 알앤디 아이피, 엘엘씨 | 무스카린 수용체 안타고니스트로 유용한 4차 암모늄 디페닐메틸 화합물 |
| MX2010002576A (es) | 2007-09-07 | 2010-04-01 | Theravance Inc | Compuestos que contienen guanidina, utiles como antagonistas de los receptores muscarinicos. |
| EP2222637A1 (en) | 2007-12-14 | 2010-09-01 | Theravance, Inc. | Amidine-containing compounds useful as muscarinic receptor antagonists |
| DE102008020746A1 (de) | 2008-04-25 | 2009-10-29 | Saltigo Gmbh | Verfahren zur Herstellung von quarternären Salzen von Piperidyl Estern der Mandelsäure |
| EP2935249B1 (en) | 2012-12-19 | 2018-12-12 | Novartis AG | Autotaxin inhibitors |
| JP6223543B2 (ja) | 2013-03-15 | 2017-11-01 | ボドール ラボラトリーズ, インコーポレイテッド | 多汗症の処置のための抗コリン作用性グリコピロレートエステル |
| US20160368873A1 (en) * | 2014-02-17 | 2016-12-22 | Ltt Bio-Pharma Co., Ltd. | Optically Active Form of Mepenzolate, and Ameliorating Agent for Chronic Obstructive Pulmonary Disease Which Contains Same as Active Ingredient |
| US20150259283A1 (en) | 2014-03-13 | 2015-09-17 | Brickell Biotech, Inc. | Formulation for soft anticholinergic analogs |
| EP3134398A1 (en) | 2014-04-24 | 2017-03-01 | Novartis Ag | Autotaxin inhibitors |
| US10472664B2 (en) | 2014-10-03 | 2019-11-12 | Institute For Cancer Research | Screening assay for identification of poly(ADP-ribose) polymerase 1 inhibitors |
| EP3200792A4 (en) | 2014-10-03 | 2018-05-09 | The Institute for Cancer Research d/b/a The Research Institute of Fox Chase Cancer Center | Poly (adp-ribose) polymerase 1 inhibitors structurally unrelated to nad |
| HK1253236A1 (zh) | 2015-07-21 | 2019-06-14 | 博多尔实验仪器公司 | 软性抗胆碱能药类似物的制剂 |
| TWI719046B (zh) | 2016-07-21 | 2021-02-21 | 美商波德實驗股份有限公司 | 軟性抗膽鹼類似物之製劑 |
| US11377422B2 (en) | 2019-03-11 | 2022-07-05 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| CA3155568A1 (en) | 2019-11-06 | 2021-05-14 | Bridget Mccarthy Cole | Charged ion channel blockers and methods for use |
| US11332446B2 (en) * | 2020-03-11 | 2022-05-17 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| US12162851B2 (en) | 2020-03-11 | 2024-12-10 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2746966A (en) * | 1953-11-02 | 1956-05-22 | Lakeside Lab Inc | Esters of bis-(nu-substituted-3-hydroxypiperidinium) alkanes |
| GB833820A (en) * | 1957-10-17 | 1960-04-27 | Beecham Res Lab | Improvements in or relating to the preparation of pyrrolidyl esters and quaternary compounds thereof |
| US2956062A (en) * | 1959-02-26 | 1960-10-11 | Robins Co Inc A H | Esters of amino alcohols |
| JPS6018661B2 (ja) | 1976-01-01 | 1985-05-11 | 太田製薬株式会社 | 1−(1,3−ジオキソラン−4−イルメチル)ピペリジノ−ル誘導体 |
| JPS5427570A (en) | 1977-07-30 | 1979-03-01 | Ota Pharma | Stereoisomer of 44acyloxyy11 alkyll11*1*33dioxolanee44 ylmethyl* pideridinium salt derivative |
| JPS5679688A (en) | 1979-12-04 | 1981-06-30 | Ota Seiyaku Kk | 4-acyloxy-1- 1,3-dioxoran-2-ylmethyl piperidine derivative and its production |
| JPS5835177A (ja) * | 1981-08-26 | 1983-03-01 | Dainippon Pharmaceut Co Ltd | 2−環状アミノ−2−(1,2−ベンズイソキサゾ−ル−3−イル)酢酸エステル類並びにその酸付加塩類および第4級アンモニウム塩類 |
| JPS58208270A (ja) | 1982-05-28 | 1983-12-03 | Dainippon Pharmaceut Co Ltd | α−環状アミノフエニル酢酸エステル類並びにその酸付加塩類及び第4級アンモニウム塩類 |
| GB9023023D0 (en) | 1990-10-23 | 1990-12-05 | Barlow Richard B | Pharmaceutical compositions |
| SI0937041T1 (en) | 1996-11-11 | 2003-10-31 | Christian R. Noe | Use of a pharmaceutically acceptable salt of (3R,2'R)-3-((Cyclopently-hydroxyphenylacetyl)oxy)-1,1-dimethyl-pyrrolidinium for the preparation of a medicament |
| EP1302458A4 (en) | 2000-07-11 | 2005-10-19 | Banyu Pharma Co Ltd | ESTERDERIVATE |
| ES2206021B1 (es) | 2002-04-16 | 2005-08-01 | Almirall Prodesfarma, S.A. | Nuevos derivados de pirrolidinio. |
| WO2004056767A1 (en) * | 2002-12-23 | 2004-07-08 | Ranbaxy Laboratories Limited | 1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists |
| PE20050231A1 (es) * | 2003-06-24 | 2005-05-20 | Novartis Ag | Derivados de piperidinium y pirrolidinium como antagonistas del receptor muscarinico m3 |
| EP1781607A2 (en) * | 2004-08-19 | 2007-05-09 | Ranbaxy Laboratories Limited | Pyrrolidine derivatives as muscarinic receptor antagonists |
-
2004
- 2004-12-24 GB GBGB0428418.8A patent/GB0428418D0/en not_active Ceased
-
2005
- 2005-12-22 KR KR1020077014261A patent/KR101259654B1/ko not_active Expired - Fee Related
- 2005-12-22 PT PT05820639T patent/PT1831208E/pt unknown
- 2005-12-22 RU RU2007128085/04A patent/RU2394031C2/ru not_active IP Right Cessation
- 2005-12-22 WO PCT/EP2005/013897 patent/WO2006066929A1/en not_active Ceased
- 2005-12-22 CA CA002589133A patent/CA2589133A1/en not_active Abandoned
- 2005-12-22 JP JP2007547368A patent/JP2008525359A/ja active Pending
- 2005-12-22 ES ES05820639T patent/ES2370832T3/es not_active Expired - Lifetime
- 2005-12-22 US US11/721,989 patent/US8153669B2/en not_active Expired - Fee Related
- 2005-12-22 AU AU2005318424A patent/AU2005318424B2/en not_active Ceased
- 2005-12-22 MX MX2007007722A patent/MX2007007722A/es active IP Right Grant
- 2005-12-22 AT AT05820639T patent/ATE521606T1/de active
- 2005-12-22 EP EP05820639A patent/EP1831208B1/en not_active Expired - Lifetime
- 2005-12-22 BR BRPI0519292-7A patent/BRPI0519292A2/pt not_active IP Right Cessation
- 2005-12-22 PL PL05820639T patent/PL1831208T3/pl unknown
- 2005-12-22 CN CN2005800429764A patent/CN101080405B/zh not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006512301A5 (cg-RX-API-DMAC7.html) | ||
| JP2010520228A5 (cg-RX-API-DMAC7.html) | ||
| KR101329112B1 (ko) | (3r,5r)-7-〔2-(4-플루오로페닐)-5-이소프로필-3-페닐-4-〔(4-히드록시 메틸 페닐 아미노)카르보닐〕-피롤-1-일〕-3,5-디히드록시 헵탄산 헤미 칼슘염의 제조 방법 | |
| JP2008523130A5 (cg-RX-API-DMAC7.html) | ||
| JP2549609B2 (ja) | 置換ピペリジンの光学分割法 | |
| MXPA02006415A (es) | Procedimiento para preparar tolterodina y analogos de la misma asi como los intermediarios preparados en el procedimiento. | |
| TW201434851A (zh) | 合成e1活化酶抑制劑之方法 | |
| RU2101279C1 (ru) | Способ получения производных (s)-3-амино-1-бензил-пирролидина, производные (s)-азиридина в качестве промежуточных соединений для их синтеза и 1-бензил-3-(s)-[2-(s)-(трет-бутоксикарбониламино)пропиониламино]-пирролидин в качестве промежуточного продукта для синтеза антибактериальных агентов на основе хинолона | |
| US8378119B2 (en) | Method for producing asymmetric tetrasubstituted carbon atom-containing compound | |
| US4501901A (en) | Method for making substituted prolines | |
| SK14799A3 (en) | Process for the preparation of 2-aryl-5-(perfluoroalkyl)pyrrole compounds from n-(perfluoroalkylmethyl)arylimidoyl chloride compounds | |
| JP2000247980A (ja) | (−)ピリドベンゾオキサジンカルボン酸誘導体の製造方法 | |
| KR101032600B1 (ko) | 고순도 레바미피드의 제조방법 | |
| JP2008290969A (ja) | アミノアセチルピロリジン誘導体の製造方法 | |
| JPWO1998047867A1 (ja) | アゼチジン−2−カルボン酸及びその中間体の製造方法 | |
| JP4484525B2 (ja) | ニューロテンシン活性2,3−ジアリール−ピラゾリジン誘導体 | |
| JP2008239543A (ja) | ビシクロアミノアセチルピロリジンカルボニトリル誘導体の製造方法およびその製造中間体 | |
| CN104292293B (zh) | 一种度他雄胺杂质i的制备方法 | |
| JP2022008191A (ja) | tert-ブチル N-((1R,2S,5S)-2-((2-((5-クロロピリジン-2-イル)アミノ)-2-オキソアセチル)アミノ)-5-(ジメチルカルボニル)シクロヘキシル)カルバメートの調製のための方法 | |
| US5466828A (en) | Chiral 3-cyano-1-substituted-pyrrolidines | |
| US20070129547A1 (en) | Process to prepare substituted imidazopyrazine compounds | |
| JP4057088B2 (ja) | ピロリジン誘導体の製造方法 | |
| WO2013027835A1 (ja) | 光学活性ナフタレン化合物の製法 | |
| JP5236627B2 (ja) | 不斉四置換キノロンカルボン酸の製造方法およびその製造中間体 | |
| JP2000026408A (ja) | 対掌体的に純粋なピロリジン誘導体、その塩、それらの製造方法 |